9-21971061-C-G

Variant summary

Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PM5

The NM_000077.5(CDKN2A):​c.298G>C​(p.Ala100Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A100L) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 32)

Consequence

CDKN2A
NM_000077.5 missense

Scores

3
7
8

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.646
Variant links:
Genes affected
CDKN2A (HGNC:1787): (cyclin dependent kinase inhibitor 2A) This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. [provided by RefSeq, Sep 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 6 ACMG points.

PM1
In a helix (size 9) in uniprot entity CDN2A_HUMAN there are 10 pathogenic changes around while only 2 benign (83%) in NM_000077.5
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chrnull-null-null-null is described in UniProt as null.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDKN2ANM_000077.5 linkc.298G>C p.Ala100Pro missense_variant Exon 2 of 3 ENST00000304494.10 NP_000068.1 P42771-1K7PML8
CDKN2ANM_058195.4 linkc.341G>C p.Gly114Ala missense_variant Exon 2 of 3 ENST00000579755.2 NP_478102.2 Q8N726-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDKN2AENST00000304494.10 linkc.298G>C p.Ala100Pro missense_variant Exon 2 of 3 1 NM_000077.5 ENSP00000307101.5 P42771-1
CDKN2AENST00000579755.2 linkc.341G>C p.Gly114Ala missense_variant Exon 2 of 3 1 NM_058195.4 ENSP00000462950.1 Q8N726-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.97
BayesDel_addAF
Pathogenic
0.23
D
BayesDel_noAF
Benign
-0.20
CADD
Benign
22
DANN
Benign
0.84
DEOGEN2
Uncertain
0.42
T;T;.;.;.;.;T;.
Eigen
Benign
-0.22
Eigen_PC
Benign
-0.072
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Uncertain
0.93
D;D;.;D;.;D;D;D
M_CAP
Pathogenic
0.41
D
MetaRNN
Uncertain
0.58
D;D;D;D;D;D;D;D
MetaSVM
Benign
-0.91
T
PrimateAI
Uncertain
0.54
T
PROVEAN
Uncertain
-3.1
D;.;.;D;.;.;.;.
REVEL
Uncertain
0.30
Sift
Benign
0.21
T;.;.;T;.;.;.;.
Sift4G
Benign
0.21
T;T;T;T;T;T;T;T
Polyphen
1.0
D;.;.;.;.;.;.;.
Vest4
0.59
MutPred
0.36
Loss of catalytic residue at A100 (P = 0.0197);Loss of catalytic residue at A100 (P = 0.0197);.;Loss of catalytic residue at A100 (P = 0.0197);.;.;.;.;
MVP
0.97
MPC
1.4
ClinPred
0.53
D
GERP RS
5.0
Varity_R
0.52
gMVP
0.88

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr9-21971060; COSMIC: COSV58704405; COSMIC: COSV58704405; API